Immunologically privileged sites, Adv Immunol, vol.25, pp.1-54, 1977. ,
Transplantation of the rat sarcoma in adult heterogeneous animals, Japan Med World, vol.1, pp.14-19, 1921. ,
Structural and functional features of central nervous system lymphatic vessels, Nature, vol.523, pp.337-378, 2015. ,
A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules, J Exp Med, vol.212, pp.991-1000, 2015. ,
Cerebral lymphatic drainage: implication in the brain immune privilege, Med Sci (Paris), vol.31, pp.953-959, 2015. ,
Human and nonhuman primate meninges harbor lymphatic vessels that can be visualized noninvasively by MRI, Elife, vol.6, p.29738, 2017. ,
Meningeal lymphatic vessel flow runs countercurrent to venous flow in the superior sagittal sinus of the human brain, Tomography, vol.4, pp.99-104, 2018. ,
CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature, Nat Neurosci, vol.21, pp.1380-91, 2018. ,
The lymphatic vasculature in disease, Nat Med, vol.17, pp.1371-80, 2011. ,
Genetics of lymphatic anomalies, J Clin Invest, vol.124, pp.898-904, 2014. ,
Lower extremity lymphedema update: pathophysiology, diagnosis, and treatment guidelines, J Am Acad Dermatol, vol.59, pp.324-355, 2008. ,
The lymphatic vasculature: development and role in shaping immunity, Immunol Rev, vol.271, pp.276-92, 2016. ,
Inflamed lymphatic endothelium suppresses dendritic cell maturation and function via mac-1/ICAM-1-dependent mechanism, J Immunol, vol.183, pp.1767-79, 2009. ,
Homing and cellular traffic in lymph nodes, Nat Rev Immunol, vol.3, pp.867-78, 2003. ,
Development and plasticity of meningeal lymphatic vessels, J Exp Med, vol.214, pp.3645-67, 2017. ,
Role of the cervical lymphatics in the Th2-type hierarchy of CNS immune regulation, J Neuroimmunol, vol.101, pp.111-138, 1999. ,
Review: cerebral amyloid angiopathy, prion angiopathy, CADASIL and the spectrum of protein elimination failure angiopathies (PEFA) in neurodegenerative disease with a focus on therapy, Neuropathol Appl Neurobiol, vol.39, pp.593-611, 2013. ,
Inflammation in neurodegenerative diseases, Immunology, vol.129, pp.154-69, 2010. ,
A new look at cerebrospinal fluid circulation, Fluids Barriers CNS, vol.11, p.10, 2014. ,
Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology, Neurochem Int, vol.45, pp.545-52, 2004. ,
The role of brain barriers in fluid movement in the CNS: is there a 'glymphatic' system?, Acta Neuropathol, vol.135, pp.387-407, 2018. ,
Mechanisms of fluid movement into, through and out of the brain: evaluation of the evidence, Fluids Barriers CNS, vol.11, p.26, 2014. ,
The brain interstitial system: anatomy, modeling, in vivo measurement, and applications, Prog Neurobiol, vol.157, pp.230-276, 2017. ,
A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta, Sci Transl Med, vol.4, pp.147-111, 2012. ,
Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology, Neuropathol Appl Neurobiol, vol.34, pp.131-175, 2008. ,
Convectionenhanced delivery to the central nervous system, J Neurosurg, vol.122, pp.697-706, 2015. ,
Drainage of interstitial fluid from different regions of rat brain, Am J Physiol, vol.246, pp.835-879, 1984. ,
CSF drains directly from the subarachnoid space into nasal lymphatics in the rat. anatomy, histology and immunological significance, Neuropathol Appl Neurobiol, vol.19, pp.480-488, 1993. ,
Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood-brain barrier, Fluids Barriers CNS, vol.15, p.30, 2018. ,
The pericyte-glia interface at the blood-brain barrier, Clin Sci (Lond), vol.132, pp.361-74, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02074159
The blood-brain barrier, Cold Spring Harb Perspect Biol, vol.7, p.20412, 2015. ,
Blood-brain barrier dysfunction and epilepsy: pathophysiologic role and therapeutic approaches, Epilepsia, vol.53, pp.1877-86, 2012. ,
Imaging bloodbrain barrier dysfunction as a biomarker for epileptogenesis, Brain, vol.140, pp.1692-705, 2017. ,
Overview and introduction: the blood-brain barrier in health and disease, Epilepsia, vol.53, issue.6, pp.1-6, 2012. ,
Long-lasting pro-ictogenic effects induced in vivo by rat brain exposure to serum albumin in the absence of concomitant pathology, Epilepsia, vol.53, pp.1887-97, 2012. ,
Blood-brain barrier disruption in post-traumatic epilepsy, J Neurol Neurosurg Psychiatry, vol.79, pp.774-781, 2008. ,
Thrombin regulation of synaptic plasticity: implications for physiology and pathology, Exp Neurol, vol.247, pp.595-604, 2013. ,
In vivo and in vitro effects of pilocarpine: relevance to ictogenesis, Epilepsia, vol.48, pp.1934-1980, 2007. ,
Glutamate-mediated bloodbrain barrier opening: implications for neuroprotection and drug delivery, J Neurosci, vol.36, pp.7727-7766, 2016. ,
Seizure progression and inflammatory mediators promote pericytosis and pericyte-microglia clustering at the cerebrovasculature, Neurobiol Dis, vol.113, pp.70-81, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02071090
Immunity and inflammation in epilepsy, Cold Spring Harb Perspect Med, vol.6, p.22699, 2015. ,
Inflammatory pathways of seizure disorders, Trends Neurosci, vol.37, pp.55-65, 2014. ,
Brain magnetic resonance in status epilepticus: a focused review, Seizure, vol.38, pp.63-70, 2016. ,
Blood-brain barrier breakdown following traumatic brain injury: a possible role in posttraumatic epilepsy, Cardiovasc Psychiatry Neurol, p.765923, 2011. ,
Blood-brain barrier damage and brain penetration of antiepileptic drugs: role of serum proteins and brain edema, Epilepsia, vol.50, pp.664-77, 2009. ,
Chronic traumatic encephalopathy in a national football league player: part II, Neurosurgery, vol.59, pp.1086-92, 2006. ,
Chronic traumatic encephalopathy in a national football league player, Neurosurgery, vol.57, pp.128-162, 2005. ,
Blood-brain barrier, bulk flow, and interstitial clearance in epilepsy, J Neurosci Methods, vol.260, pp.118-142, 2016. ,
Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3, Nat Med, vol.7, pp.199-205, 2001. ,
A novel technique for morphometric quantification of subarachnoid hemorrhage-induced microglia activation, J Neurosci Methods, vol.229, pp.44-52, 2014. ,
Targeting neurodegeneration to prevent post-traumatic epilepsy, Neurobiol Dis, vol.123, pp.100-109, 2019. ,
In search of antiepileptogenic treatments for post-traumatic epilepsy, Neurobiol Dis, vol.123, pp.86-99, 2019. ,
Hyperphosphorylated tau is implicated in acquired epilepsy and neuropsychiatric comorbidities, Mol Neurobiol, vol.49, pp.1532-1541, 2014. ,
Infantile tauopathies: hemimegalencephaly; tuberous sclerosis complex; focal cortical dysplasia 2; ganglioglioma, Brain Dev, vol.37, pp.553-62, 2015. ,
Pathological tau tangles localize to focal cortical dysplasia in older patients, Epilepsia, vol.48, pp.1447-54, 2007. ,
Neurofibrillary tangle pathology and braak staging in chronic epilepsy in relation to traumatic brain injury and hippocampal sclerosis: a post-mortem study, Brain, vol.134, pp.2969-81, 2011. ,
Is phosphorylated tau unique to chronic traumatic encephalopathy? phosphorylated tau in epileptic brain and chronic traumatic encephalopathy, Brain Res, vol.1630, pp.225-265, 2016. ,
Cerebrospinal fluid tau proteins in status epilepticus, Epilepsy Behav, vol.49, pp.150-154, 2015. ,
Dysregulation of tau phosphorylation in mouse brain during excitotoxic damage, J Alzheimers Dis, vol.17, pp.531-540, 2009. ,
Rapid accumulation of endogenous tau oligomers in a rat model of traumatic brain injury: possible link between traumatic brain injury and sporadic tauopathies, J Biol Chem, vol.288, pp.17042-50, 2013. ,
Sodium selenate reduces hyperphosphorylated tau and improves outcomes after traumatic brain injury, Brain, vol.138, pp.1297-313, 2015. ,
Amyloid-beta/fyninduced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of alzheimer's disease, J Neurosci, vol.31, pp.700-711, 2011. ,
The tau/A152T mutation, a risk factor for frontotemporal-spectrum disorders, leads to NR2B receptor-mediated excitotoxicity, EMBO Rep, vol.17, pp.552-69, 2016. ,
Microtubuleassociated proteins in mesial temporal lobe epilepsy with and without psychiatric comorbidities and their relation with granular cell layer dispersion, Biomed Res Int, p.960126, 2013. ,
Atypical, non-standard functions of the microtubule associated tau protein, Acta Neuropathol Commun, vol.5, p.91, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-01833336
Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert, J Neurochem, vol.99, pp.1445-55, 2006. ,
Activation of AKT/ GSK3beta pathway by TDZD-8 attenuates kainic acid induced neurodegeneration but not seizures in mice, Neurotoxicology, vol.46, pp.44-52, 2015. ,
Targeting hyperphosphorylated tau with sodium selenate suppresses seizures in rodent models, Neurobiol Dis, vol.45, pp.897-901, 2012. ,
Sodium selenate retards epileptogenesis in acquired epilepsy models reversing changes in protein phosphatase 2A and hyperphosphorylated tau, Brain, vol.139, pp.1919-1957, 2016. ,
The chronic and evolving neurological consequences of traumatic brain injury, Lancet Neurol, vol.16, pp.813-838, 2017. ,
Neurodegenerative diseases: the immunological perspective, J Neuroimmunol, vol.313, pp.109-124, 2017. ,
A perspective on roles played by innate and adaptive immunity in the pathobiology of neurodegenerative disorders, J Neuroimmune Pharmacol, vol.10, pp.645-50, 2015. ,
Innate and adaptive immunity in human epilepsies, Epilepsia, vol.58, issue.3, pp.57-68, 2017. ,
T cells in the central nervous system: messengers of destruction or purveyors of protection?, Immunology, vol.141, pp.340-344, 2014. ,
Antigen-specific immune reactions to ischemic stroke, Front Cell Neurosci, vol.8, p.278, 2014. ,
Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs, J Immunol, vol.169, pp.5415-5438, 2002. ,
A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation, J Neuroimmunol, vol.90, pp.113-134, 1998. ,
Pathophysiology of the lymphatic drainage of the central nervous system: implications for pathogenesis and therapy of multiple sclerosis, Pathophysiology, vol.17, pp.295-306, 2010. ,
Vascular, glial, and lymphatic immune gateways of the central nervous system, Acta Neuropathol, vol.132, pp.317-355, 2016. ,
Drainage of brain extracellular fluid into blood and deep cervical lymph and its immunological significance, Brain Pathol, vol.2, pp.269-76, 1992. ,
Experimental manipulations of afferent immune responses influence efferent immune responses to brain tumors, Cancer Immunol Immunother, vol.57, pp.1323-1356, 2008. ,
Regulatory T cells in central nervous system injury: a double-edged sword, J Immunol, vol.193, pp.5013-5035, 2014. ,
Immune response in deep cervical lymph nodes and spleen in the mouse after antigen deposition in different intracerebral sites, Scand J Immunol, vol.28, pp.563-71, 1988. ,
What is immune privilege (not)?, Trends Immunol, vol.28, pp.12-20, 2007. ,
ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology, Epilepsia, vol.58, pp.512-533, 2017. ,
The diagnosis and treatment of autoimmune encephalitis, J Clin Neurol, vol.12, pp.1-13, 2016. ,
The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins, Curr Opin Neurol, vol.23, pp.144-50, 2010. ,
Autoimmune encephalitis, BMJ, vol.342, 1918. ,
Focal seizures due to chronic localized encephalitis, Neurology, vol.8, pp.435-480, 1958. ,
Mechanisms of epileptogenesis in pediatric epileptic syndromes: rasmussen encephalitis, infantile spasms, and febrile infection-related epilepsy syndrome (FIRES), Neurotherapeutics, vol.11, pp.297-310, 2014. ,
Chronic encephalitis and epilepsy. Rasmussen's syndrome Ed, pp.79-110, 1991. ,
Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances, Lancet Neurol, vol.13, pp.195-205, 2014. ,
Local-clonal expansion of infiltrating T lymphocytes in chronic encephalitis of rasmussen, J Immunol, vol.158, pp.1428-1465, 1997. ,
CD8 + T-cell clones dominate brain infiltrates in rasmussen encephalitis and persist in the periphery, Brain, vol.132, pp.1236-1282, 2009. ,
Phenotypic and functional complexity of brain-infiltrating T cells in rasmussen encephalitis, Neurol Neuroimmunol Neuroinflamm, vol.5, p.419, 2017. ,
, Handb Clin Neurol, vol.111, pp.511-520, 2013.
Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in rasmussen's encephalitis, Ann Neurol, vol.51, pp.311-319, 2002. ,
Epileptic encephalitis: the role of the innate and adaptive immune system, Brain Pathol, vol.22, pp.412-433, 2012. ,
Brain endothelial cell-cell junctions: how to "open" the blood brain barrier, Curr Neuropharmacol, vol.6, pp.179-92, 2008. ,
Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells, J Immunol, vol.156, pp.2558-65, 1996. ,
Inflammation-associated lymphangiogenesis: a double-edged sword?, J Clin Invest, vol.124, pp.936-978, 2014. ,
Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution, Blood, vol.113, pp.5650-5659, 2009. ,
An important role of lymphatic vessel activation in limiting acute inflammation, Blood, vol.117, pp.4667-78, 2011. ,
Inhibition of lymphangiogenesis and lymphatic drainage via vascular endothelial growth factor receptor 3 blockade increases the severity of inflammation in a mouse model of chronic inflammatory arthritis, Arthritis Rheum, vol.60, pp.2666-76, 2009. ,
Lymphatic vessels in health and disease, Wiley Interdiscip Rev Syst Biol Med, vol.5, pp.111-135, 2013. ,
Therapeutic lymphangiogenesis with human recombinant VEGF-C, FASEB J, vol.16, pp.1985-1992, 2002. ,
Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation, Nat Med, vol.13, pp.1458-66, 2007. ,
VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study, Angiogenesis, vol.18, pp.313-339, 2015. ,
Stimulation and inhibition of lymphangiogenesis via adeno-associated viral gene delivery, Methods Mol Biol, vol.1846, pp.291-300, 2018. ,